← Dashboard

The Research

The whole picture, organized. Tap a section to expand. Read only what you have energy for.

Why treatment hasn't worked
TL;DR — Persister cells survive antibiotics, co-infections require different drugs, and equivocal testing often misses the real problem.

Large trials of extended antibiotics mostly didn't show benefit for chronic Lyme. But those trials share three blind spots:

If doxycycline and herbals haven't moved the needle, the likely answer isn't "more doxycycline" — it's "different problem, different drug."

The Bartonella connection
TL;DR — ~88% of patients with neuropsychiatric symptoms in one Breitschwerdt study had Bartonella. Depression + skin + fatigue is the textbook triad. Standard tests miss 30–40%.

What it is: a bacteria carried by the same ticks (also cats, fleas). It hides inside the lining of blood vessels, which is why it's hard to find and hard to kill.

The psych symptoms aren't psychiatric. Bartonella inflames brain tissue, causing depression, anxiety, rage, and panic. In documented cases these lift with antibiotics, not antidepressants — which is why SSRIs often don't touch Lyme-era depression.

Skin clues: stretch-mark-looking striae (red or purple) that appear without weight change, mystery rashes, bumps under the skin.

Why it gets missed: Quest and LabCorp use IFA serology with poor sensitivity. IGeneX ImmunoBlot and Galaxy ePCR are ~10× more sensitive. Galaxy was founded by the NC State vet-school researcher who has published the most on Bartonella — not a fringe outfit.

Treatment (if positive): azithromycin or clarithromycin + rifampin, often 3+ months. Methylene blue is showing up in newer protocols. Rifampin is always combined — never solo, it breeds resistance.

Babesia & other co-infections
TL;DR — Babesia is a malaria-like parasite needing atovaquone + azithromycin. Ehrlichia, Anaplasma, and Mycoplasma also travel with Lyme and change the treatment plan.

Babesia is a protozoan (not a bacterium). Same ticks, different drugs. Classic signs: night sweats, air hunger (feeling like you can't get a full breath), and profound fatigue. Atovaquone + azithromycin is the standard combo. For treatment-refractory cases, adding clindamycin or extended courses.

Test for both B. microti and B. duncani. They need separate tests — no cross-reactivity. Duncani is more common in the western US (including Colorado).

Ehrlichia / Anaplasma / Mycoplasma are less common but worth ruling out, especially if there's a history of high fevers, low platelets, or neuropathic pain patterns.

Persister-targeting drugs
TL;DR — Disulfiram (~67% fatigue improvement), dapsone (~45% one-year remission), methylene blue — these target the dormant bacteria that regular antibiotics miss.

Disulfiram: an old alcoholism drug that, in lab studies, kills Lyme persister cells that doxycycline can't touch. A case series of treatment-refractory patients showed substantial symptom improvement. Side effects can be rough — needs a doctor who's done this before.

Dapsone (Horowitz protocol): a leprosy drug repurposed for persistent Lyme. In a Horowitz study, roughly 45% of patients hit one-year remission. Often combined with azithromycin and rifampin.

Methylene blue: shows activity against Borrelia persisters in vitro and is being used adjunctively in some Lyme clinics. Limited published trials, lots of anecdote.

These are "when nothing else worked" drugs. They require an experienced LLMD and close monitoring.

What else could this be?
TL;DR — MCAS, mold/CIRS, thyroid, ME/CFS, POTS, and nutritional deficiencies all mimic Lyme. They can stack on top and block recovery.
Emerging treatments & clinical trials
TL;DR — Active trials at Columbia and Johns Hopkins. A Hopkins psilocybin trial for PTLDS showed ~40% symptom improvement at 6 months. Hyperthermia, IVIG, and LDN are also being studied.

Psilocybin for PTLDS (Johns Hopkins): early data in 2026 showed roughly 40% symptom reduction sustained at 6 months. Mechanism thought to be neuroinflammation-related. Still experimental.

IVIG: intravenous immunoglobulin for autoimmune-flavored Lyme complications, especially peripheral neuropathy. Expensive and insurance-dependent.

LDN (low-dose naltrexone): neuromodulator with anti-inflammatory effects. Used off-label in chronic illness. Cheap, generally well tolerated.

Hyperthermia: whole-body hyperthermia protocols (primarily in Germany). Some case reports, limited controlled data.

Columbia Lyme & Tick-Borne Diseases Center and Johns Hopkins Lyme Disease Research Center both run active research programs accepting patients. Worth contacting directly.

Supportive care
TL;DR — CoQ10 + NADH for fatigue. Vitamin D, B12, magnesium. Anti-inflammatory diet. Nervous system regulation. These don't cure anything, but they move the floor up.

Mitochondrial support: CoQ10 200mg + NADH 10mg together showed ~26% fatigue reduction in a Lyme study. Add PQQ and L-carnitine for bigger stacks.

Vitamin/mineral optimization: Vitamin D 40–60 ng/mL, B12 methylcobalamin, ferritin >50, RBC magnesium in the upper half of range. These are often low and easily fixed.

Anti-inflammatory diet: reducing processed carbs, seed oils, and alcohol lowers systemic inflammation. Some people benefit from gluten-free or dairy-free trials. Elimination-reintroduction over a few weeks tells you which matter.

Nervous system regulation: chronic illness keeps the sympathetic "fight-or-flight" system dominant. Breathwork, vagal exercises, and polyvagal-informed therapy help downshift. Not woo — this affects inflammation directly.

Sleep: magnesium glycinate at night, consistent wake time, early-day sunlight. Lyme disrupts sleep architecture, and recovery is sleep-limited.

Rough timeline
TL;DR — Not fast, but not forever.
Primary sources

Referenced throughout the content above. Not exhaustive.